Allergies Resources
Featured Centers
- Eating Out? Cut Calories, Heartburn
- 5 Good Ways to Save Money on Medicine
- 8 Ways to Treat Your Allergies
|
|
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
LIVOSTIN™ 0.05% (levocabastine hydrochloride ophthalmic suspension) is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis.
Read the complete drug monograph for Livostin »
Drug Description - Indications & Dosage - Side Effects & Drug Interactions - Warnings & Precautions - Contraindications - Medication Guide and More
What is Patient information?
Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.
Serious side effects are not expected with this medication.
Less serious side effects may be more likely to occur. Continue to use levocabastine ophthalmic and talk to your doctor if you experience
Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems u...
Read the complete patient information for Livostin »
Possible Side Effects - Images - What Is - How Should I Take It - What If I Miss a Dose - What Should I Avoid and More
What is Consumer information?
A concise overview of the drug for the patient or caregiver from First DataBank.
Do not use this medication to treat red or irritated eyes due to wearing contact lenses. Ask your doctor for further instructions if this occurs.
HOW TO USE: If you are using another kind of eye medication (such as drops or ointments), wait at least 5-10 minutes between applying...
Read the complete consumer information for Livostin »
Warnings - Uses - How to Use - Side Effects - Precautions - Drug Interactions and More
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Improve treatments & prevent attacks.